SCHEMBL14632838

SCHEMBL14632838

CN1CCN(c2ccc(Nc3ncc4c(=O)n(-c5ccccc5)nc(-c5cccc(Br)c5)c4n3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 1/20 0.52
▸ WEE1 P30291 6/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ MAP4K1 Q92918 1/20 0.50
▸ KCNH2 Q12809 1/20 0.49
▸ CDK4 P11802 1/20 0.49
▸ CCND1 P24385 1/20 0.49
▸ CCND2 P30279 1/20 0.49
▸ CCND3 P30281 1/20 0.49
▸ KDR P35968 2/20 0.48
▸ EGFR P00533 2/20 0.48
▸ CSF1R P07333 1/20 0.47
▸ ALK Q9UM73 2/20 0.47
▸ LCK P06239 2/20 0.47
▸ SRC P12931 2/20 0.47
▸ JAK2 O60674 2/20 0.46
▸ BRD4 O60885 2/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ INSR P06213 1/20 0.46
▸ BTK Q06187 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633618 0.92 JAK3 (0.61) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633216 0.91 LCK (0.54) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633308 0.91 JAK3 (0.53) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633397 0.91 WEE1 (0.53) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633369 0.90 WEE1 (0.56) JAK3WEE1CYP3A4KCNH2KDR
SCHEMBL14633238 0.90 WEE1 (0.61) WEE1CYP3A4KCNH2KDRLCK
SCHEMBL14633120 0.89 LCK (0.57) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633320 0.88 JAK3 (0.54) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633195 0.87 JAK3 (0.55) JAK3WEE1CYP3A4MAP4K1KCNH2
SCHEMBL14633348 0.86 WEE1 (0.53) JAK3WEE1CYP3A4MAP4K1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 JAK3 62/4885WEE1 1/4885CYP3A4 1925/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 JAK3 62/4885WEE1 1/4885CYP3A4 1925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback